<p>As RBC Capital Markets looks forward to a robust end to the year, John Hoffman and Jason Levitz, Co-Heads of Healthcare Equity Capital Markets explore how the firms who succeed in an especially dynamic market will be those willing to embrace new ways of thinking about unlocking value.</p>

As RBC Capital Markets looks forward to a robust end to the year, John Hoffman and Jason Levitz, Co-Heads of Healthcare Equity Capital Markets explore how the firms who succeed in an especially dynamic market will be those willing to embrace new ways of thinking about unlocking value.

ECM: Robust End to Year, Despite Previous Volatility

Perspectives from the cutting edge of biotech and pharma.

The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series.

Lead today. Define tomorrow.

Business

News

Investing

Business News

Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.

Share ECM: Robust End to Year, Despite Previous Volatility

Sign up to save your podcasts

ECM: Robust End to Year, Despite Previous Volatility

ECM: Robust End to Year, Despite Previous Volatility

More shows like Pathfinders in Biopharma

Pardon My Take

The Daily

Up First from NPR

The Readout Loud

Making Sense

Biotech 2050 Podcast

Business Of Biotech

BioCentury This Week

RBC's Markets in Motion

Biotech Hangout

Industries in Motion

Powering Sustainable Ideas

Macro Minutes

Strategic Alternatives

Goldman Sachs The Markets

The BioCentury Show